Epizyme, Inc.
Clinical trials sponsored by Epizyme, Inc., explained in plain language.
-
Major trial aims to control stubborn blood cancer
Disease control Recruiting nowThis large, late-stage trial is testing whether adding a new drug called tazemetostat to a standard two-drug treatment helps people with follicular lymphoma live longer without their cancer getting worse. The study is for adults whose lymphoma has returned or stopped responding t…
Phase: PHASE3 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test cancer drug safety for patients with failing livers
Knowledge-focused Recruiting nowThis study aims to understand how a cancer drug called tazemetostat is processed by the body in people who have both advanced cancer and moderate to severe liver problems. Researchers will compare blood levels and safety of the drug in these participants to others with cancer and…
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC